Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Masterman
Donna
D
Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Box 951769, Los Angeles, CA 90095-1769, USA. donnam@amgen.com
D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy*; D015140:Dementia, Vascular / Q000175:diagnosis / Q000188:drug therapy; D015577:Geriatric Assessment; D006801:Humans; D020961:Lewy Body Disease / Q000175:diagnosis / Q000188:drug therapy; D008609:Mental Status Schedule; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy
D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents